Thierry Fontanges

2.4k citations
32 papers · 2.0k · 1 hit paper · h-index 13

Impact in

  • Hepatology top 1%
    • Hepatitis C virus research
    • Liver Diseases and Immunity
    • Liver Disease and Transplantation
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

    • Hepatitis C virus research 16
    • Liver Diseases and Immunity 1
    • Hepatitis B Virus Studies 7
    • Liver Disease Diagnosis and Treatment 6

Thierry Fontanges

31 papers receiving 2.0k citations

Thierry Fontanges's Hit Papers

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial 2019 · 1.1k citations
1.1k0+2+4Years since publication2505007501000

Peers

Thierry Fontanges
Comparison fields: 5 of 81
  • Hepatology 950
  • Epidemiology 1.3k
  • Endocrinology, Diabetes and Metabolism 332
  • Oncology 202
  • Cell Biology 118
Replace Terry D. Box with:
Terry D. Box United States
Thomas E. Sepe United States
Grisell Ortiz‐Lasanta United States
Lynsey Corless United Kingdom
John J. Santoro United States
Kittichai Promrat United States
M Voiculescu Romania
Hans Orlent Belgium
Federico Rodríguez-Pérez Puerto Rico
W Knapple United States
Thierry Fontanges relative to Terry D. Box United States Terry D. Box's profile →
Citations per field
00.5×2×2.7×
Terry D. Box · 1×
Citations per year

Countries citing papers authored by Thierry Fontanges

Since Specialization
Citations

This map shows the geographic impact of Thierry Fontanges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Fontanges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Fontanges more than expected).

Fields of papers citing papers by Thierry Fontanges

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Fontanges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Fontanges. The network helps show where Thierry Fontanges may publish in the future.

Co-authors

The 25 scholars most cited alongside Thierry Fontanges, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thierry Fontanges Line = papers co-authored together Thierry Fontanges links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Hit paper breakdown →
20191063
2 1991231
3 2014213
4 2014124
5 201163
6 201155
7 201949
8 201034
9 200731
10 200830
11
[Liver damage induced by the ingestion of a product of phytotherapy containing wild germander. Four cases].
199214
12 200814
13 200714
14 201713
15 198612
16 202312
17 201012
18
[Hepavir, the first observational study of one cohort of patients treated with alpha-2a interferon, monotherapy. Evaluation of asthenia and its social consequences].
20019
19 20077
20 19867

About Thierry Fontanges

Thierry Fontanges is a scholar working on Hepatology, Epidemiology, Physiology, Pharmacology and Oncology, having authored 32 papers that have together received 2.0k indexed citations. Recurring topics across this work include Hepatitis C virus research (16 papers), Hepatitis B Virus Studies (7 papers), Liver Disease Diagnosis and Treatment (6 papers), Adenosine and Purinergic Signaling (2 papers), Biochemical and Molecular Research (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Liver Diseases and Immunity (1 paper) and Poisoning and overdose treatments (1 paper). The work is most often cited by research in Hepatology (950 citations), Epidemiology (1.3k citations), Endocrinology, Diabetes and Metabolism (332 citations), Oncology (202 citations) and Cell Biology (118 citations). Thierry Fontanges has collaborated with scholars based in France, Australia and Italy. Frequent co-authors include Denis Ouzan, Philippe Chossegros, Fabien Zoulim, Xavier Causse, Carlton Meschievitz, C. Trépo, Janice K. Albrecht, Michèle Chevallier, Michel Chousterman and Patrick Marcellin. Their work appears in journals such as Journal of Hepatology, European Journal of Gastroenterology & Hepatology, Gastroenterology, Alimentary Pharmacology & Therapeutics and Liver International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact